Is Emgality Approved for Cluster Headaches?
No, Emgality (galcanezumab) is FDA-approved only for the preventive treatment of episodic migraine in adults. It targets CGRP, a protein involved in migraine, but the label excludes cluster headaches.[1]
What Does the Clinical Evidence Show?
Two phase 3 trials (ACT1 and ACT2) tested galcanezumab for episodic cluster headache prevention but failed to meet primary endpoints—attack frequency reduction was not statistically significant versus placebo. A phase 2 trial for chronic cluster headaches also showed no benefit. Eli Lilly discontinued development for this indication in 2019.[2][3]
Why Not Approved Despite CGRP's Role in Cluster Headaches?
Cluster headaches involve CGRP release, and other CGRP blockers like Emgality work for migraines. However, trial data specific to cluster headaches didn't demonstrate efficacy. The FDA requires positive trials for new indications; negative results block approval.[4]
Are Doctors Prescribing It Off-Label?
Off-label use occurs rarely due to lack of evidence and high cost (~$700/month). Patient forums report mixed anecdotes, but no guidelines (e.g., AHS, EHF) recommend it. Risks include injection-site reactions, constipation, and rare hypersensitivity.[1][5]
What Alternatives Work for Cluster Headaches?
- Acute attacks: High-flow oxygen (100% at 12-15 L/min), sumatriptan injections/nasal spray.
- Prevention: Verapamil (first-line), galcanezumab alternatives like Emgality don't apply; instead, steroids, lithium, or topiramate.
- Emerging: Zolmitriptan nasal spray; galcanezumab competitors like fremanezumab unproven here too.[6]
When Might Approval Change?
No ongoing trials for cluster headaches per ClinicalTrials.gov. Patents on Emgality expire around 2030-2033 in major markets, but without data, biosimilars won't pursue this use. Check DrugPatentWatch.com for expiry details.[7][8]
Sources
[1]: FDA Label for Emgality
[2]: Lancet Neurology: Phase 3 Cluster Trial
[3]: Eli Lilly Press Release
[4]: AHS Position on CGRP in Cluster
[5]: Drugs.com User Reviews
[6]: UpToDate: Cluster Headache Management
[7]: ClinicalTrials.gov Search
[8]: DrugPatentWatch: Emgality Patents